Literature DB >> 3113942

In vitro activity of new antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients.

A M Horrevorts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3113942     DOI： 10.1007/bf02017629

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  6 in total

1.  In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputum.

Authors:  D A Conrad; R K Scribner; A H Weber; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

2.  Comparison between the in-vitro activity of new agents on Pseudomonas aeruginosa isolates from cystic fibrosis patients and other chronic infections.

Authors:  B Gordts; C Vandenborre; P VanderAuwera; J P Butzler
Journal:  J Antimicrob Chemother       Date:  1984-07       Impact factor: 5.790

3.  Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.

Authors:  A S Prince; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

4.  In-vitro activity of ciprofloxacin and other antibacterial agents against Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients.

Authors:  J D Klinger; S C Aronoff
Journal:  J Antimicrob Chemother       Date:  1985-06       Impact factor: 5.790

5.  In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis.

Authors:  S C Aronoff; J D Klinger
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

6.  Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.

Authors:  R K Scribner; M I Marks; A H Weber; M M Tarpay; D F Welch
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191
  6 in total
  1 in total

1.  Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.

Authors:  J W Mouton; A M Horrevorts; P G Mulder; E P Prens; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.